
Medline Inc (MDLN) Stock Forecast & Price Target
Medline Inc (MDLN) Analyst Ratings
Bulls say
Medline is attractive because its dominant U.S.-focused scale, with over 90% of revenue generated domestically, 30+ manufacturing facilities, ~45 distribution centers, and 2,000+ owned trucks, supports a resilient and highly integrated supply chain model that is hard for competitors to replicate. Its 1,300+ Prime Vendor relationships and ~$2.4B of Prime Vendor signings in 2025 create a long-duration pipeline for converting lower-margin supply-chain revenue into higher-margin Medline Brand sales, with management estimating ~$4B of current conversion opportunity that could translate into roughly $1B of incremental gross profit. Near-term demand also appears strong, as 3Q:26 revenue rose 10.4% y/y, adjusted EBITDA beat expectations even excluding an $81M tariff refund benefit, and 2027E guidance still points to high-single-digit revenue growth plus ~$80M-$90M of annualized restructuring savings.
Bears say
Medline is facing a negative setup because tariff-driven headwinds, raw-material inflation, and elevated transportation and remediation costs are compressing margins just as management expects Supply Chain Solutions margins to stay around 4.4% in 4Q after prior expectations of about 5% for FY26. Its initial FY27 framework for low-to-mid single-digit EBITDA growth already reflects a difficult cost environment, and two-thirds of the roughly $200 million increase in costs is expected in 4Q:26, raising concern around near-term earnings pressure. In addition, BBBA-related Medicaid cuts and expired exchange subsidies may reduce hospital volumes and tighten customer budgets, while competitive pressure, operational complexity, and a material debt load could further limit growth and flexibility.
This aggregate rating is based on analysts' research of Medline Inc and is not a guaranteed prediction by Public.com or investment advice.
Medline Inc (MDLN) Analyst Forecast & Price Prediction
Start investing in Medline Inc (MDLN)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Medline Inc (MDLN) Forecast
Medline Inc (MDLN) Analyst Forecast & Price Prediction
Start investing in Medline Inc (MDLN)
Order type
Buy in
Order amount
Est. shares
0 shares